Medication Review in Women With Depression and Anxiety

This study sought to assess the impact of the MMR service on identifying and resolving TRPs, improving adherence, depression and anxiety scores in females diagnosed with depression and anxiety in Jordan

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression, Anxiety Adherence, Patient Anxiety Disorders Behavior Behavioral Symptoms Depression Health Behavior Mental Disorders Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

Participants were recruited into this single-blind parallel randomized controlled trial and randomized into active and control groups. A clinical pharmacist identified TRPs for all participants. Adherence, depression and anxiety scores were assessed. Active group patients received the MMR service: pharmacist-delivered counseling and a letter with recommended changes in the patient's treatment plan was sent to the patient's psychiatrist to be applied. Control group participants did not receive the intervention. Follow-up assessments were completed for all patients at 3 months from baseline. Main outcome measures were TRPs, adherence, depression and anxiety scores.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Jordanian females or residents in Jordan for the last 12 months and planning to stay in Jordan for 6 months (the study follow-up period),
above the age of 18 years
diagnosed with depression and/or anxiety for at least 4 weeks duration
taking medications for depression and/or anxiety

Exclusion criteria

presence of a cognitive problem or sensory impairment which may prevent communication with the patient (reported by the patient's psychiatrist)
being not able to speak or write Arabic (reported by the patient)

Treatment and study plan

Medication management review

Other

The researcher screened each completed an MMR template and verified that all information in each patient template was complete. A classification system was then used to identify the TRPs which either actually or potentially interfered with the clinical outcomes for each patient.[19] This system was explained in detail and applied successfully in many previous studies.[10, 14, 20] The researcher then identified TRPs for each patient in both groups using evidence-based medicine. The TRPs including unneeded drug treatment, untreated condition/s, efficacy/effectiveness issues, safety issues, inadequate knowledge, inappropriate adherence to pharmacological therapy, inappropriate adherence to self-care activities and miscellaneous problems.

Primary outcomes

Evaluate the effect of the medication management review service delivered to females living in Jordan and diagnosed with depression and anxiety

Time frame: 6 months

the medication management review service will be measured by the reduction of treatment related number after providing the service

Secondary outcomes

Patient's satisfaction with the medication management review service

Time frame: 6 months

satisfaction will be measured by the willingness of patients to pay for the provided services

Sponsors and collaborators

Lead sponsor

Applied Science Private University

Other

Registry information

Official study title

Assessing the Impact of Medication Management Review Service for Females Diagnosed With Depression and Anxiety

Important dates

Study start: 2016
Primary completion: 2017
Study completion: 2017
First posted: Sep 9, 2019
Registry last updated: Sep 9, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed